Drug Research

An innovative system for monitoring chromosomal fragility and copy number alterations in particularly lethal tumours was described earlier this July by researchers from Cambridge University and the National Cancer Research Center in Madrid. Researchers believe this is the first time...

As infections in the U.S. continue to be at high levels, the Food and Drug Administration on 13th July approved a fourth vaccination for COVID-19 prevention, authorising Novavax's coronavirus jab for emergency use in adults. The Maryland-based drugmaker's early results on...

Aspen successfully expands CMO activities with filling equipment from Syntegon At first sight, anesthetics and vaccines don’t have much in common: while the first have a narcotic effect, the latter prevent diseases from breaking out or taking a severe course....

The findings of a phase 1 trial examining a medication mixture targeting multiple mutant variants of cancer's 'death star' protein have been released by the Institute of Cancer Research (ICR) in London and The Royal Marsden NHS Foundation Trust. In...

Citius Pharmaceuticals, Inc., a late-stage biopharmaceutical company, announced that it has selected Biorasi, LLC (Biorasi), a global clinical research organization (CRO), to help expand the company's phase 3 Mino-Lok trial to additional sites outside the United States. If approved,...

Oragenics, Inc. announced it has entered into an agreement with KBI Biopharma, Inc. for the process transfer, process optimization and cGMP manufacturing of the Company’s intranasal vaccine candidate NT-CoV2-1, which is expressed in a proprietary CHO cell line. The...

WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, announced the launch of Tetracycline-Enabled Self-Silencing Adenovirus (TESSA™). This technology is a state-of-the-art novel process for transfection-free, scalable manufacture of adeno-associated virus (AAV) at Good Manufacturing Practice...